PressDigest

Teva weighs Mylan bid to disrupt Perrigo deal

Teva Pharmaceutical Industries, the Israeli generic drug maker, is weighing a takeover offer for rival Mylan to thwart the latter’s proposed $28.9bn acquisition of Ireland-based Perrigo, The Wall Street Journal has learnt.

WSJ Logo
110-Hour Workweeks Drove Young Bankers at a Boutique Firm to the BrinkExternal link

110-Hour Workweeks Drove Young Bankers at a Boutique Firm to the Brink